Key result
Emergency catecholamine administration in a patient with unrecognized takotsubo cardiomyopathy exacerbated left ventricular dysfunction, which completely resolved upon catecholamine withdrawal and initiation of beta-blocker therapy.
Case Report (n=1)
No
Emergency catecholamine administration can be deleterious in unrecognized takotsubo cardiomyopathy, highlighting the importance of early echocardiography to detect dynamic LV outflow tract obstruction and avoid inotropic therapy.
Catecholamines may worsen unrecognized takotsubo; case report leaves open whether early echocardiography alters acute management.
A case is presented of initially unrecognized takotsubo cardiomyopathy with a dramatic clinical course after emergency catecholamine treatment for circulatory support during stress-induced cardiac syncope followed by complete recovery of cardiac function after catecholamine withdrawal and starting beta-blocker therapy. Echocardiography including 2D-strain imaging suggested that the left ventricle (LV) wall motion abnormality was mainly the consequence of geometry-induced regional differences in wall stress (progressively amplified by catecholamines), which might be another possible pathophysiological mechanism involved in the development of LV dysfunction in takotsubo cardiomyopathy. This case also suggests that in emergency, before coronary angiography is possible, echocardiography can be helpful for initial therapeutic decisions, especially to avoid emergency inotropic therapy in such patients.
No takes yet. Share an insight, caveat, or question.
Dandel et al. (2009) conducted a case report in Takotsubo cardiomyopathy (n=1). Catecholamine treatment (epinephrine, dobutamine, norepinephrine) vs. Catecholamine withdrawal and beta-blocker therapy was evaluated on Left ventricular functional recovery. Emergency catecholamine administration in a patient with unrecognized takotsubo cardiomyopathy exacerbated left ventricular dysfunction, which completely resolved upon catecholamine withdrawal and initiation of beta-blocker therapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: